PUNE, India, September 8, 2016 /PRNewswire/ --
According to a new market research report "Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers) - Trends & Global Forecasts to 2021", published by MarketsandMarkets, This report studies the market for the forecast period of 2016 to 2021. This market is expected to reach 12.69 Billion by 2021 from USD 5.77 Billion in 2016, growing at a CAGR of 17.1%.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 102 market data Tables and 43 Figures spread through 184 Pages and in-depth TOC on "Molecular Biology Enzymes and Kits & Reagents Market"
Early buyers will receive 10% customization on this report.
A number of factors such as technological advancements in the life sciences industry, increased research activities in the pharmaceutical and biotechnology sectors, rising incidences of infectious diseases and genetic disorders, and successful completion of Human Genome Project are expected to drive the growth of the Molecular Biology Enzymes Market during the forecast period.
In this report, the molecular biology enzymes and kits & reagents market is segmented on the basis of product, application, end user, and region. Based on product, Molecular Biology Enzymes Market is categorized into kits & reagents and enzymes. The kits & reagents segment is expected to account for the largest share of the market in 2016. This segment is also estimated to grow at the faster growth rate during the forecast period (2016-2021).
Based on application, the molecular biology enzymes and kits & reagents market is segmented into PCR, sequencing, restriction digestion, cloning, epigenetics, and synthetic biology, among others. The PCR segment is expected to account for the largest share of the market in 2016. However, the sequencing segment is expected to grow at the highest CAGR during the forecast period.
On the basis of end user, the Molecular Biology Enzymes Market is segmented academic & research institutes, hospitals & diagnostic centers, and pharmaceutical & biotechnology companies, among other end users. The academic & research institutes segment is expected to account for the largest share of the market in 2016. However, the hospitals & diagnostic centers are projected to grow at the highest CAGR during the forecast period.
Geographically, the molecular biology enzymes and kits & reagents market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, the Middle East, and Africa). North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is projected to grow at the highest CAGR and serves as a revenue pocket for companies offering molecular biology enzymes and kits & reagents.
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=164131709
Prominent players in the global Molecular Biology Enzymes Market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), New England Biolabs, Inc. (U.S.), Promega (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-la Roche Ltd. (Switzerland), Takara Bio Inc. (Japan), QIAGEN N.V. (The Netherlands), and Becton, Dickinson and Company (U.S.)
Browse Related Reports:
Genomics Market by Product (Instruments, Consumables), Technology (Sequencing, PCR, Microarray), Application (Diagnostics, Personalized Medicine), Process (Library Preparation, Sequencing & Imaging), End User - Trends & Global Forecasts to 2020.
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune - 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets